Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19.
Sandoe JAT, Grozeva D, Albur M, Bond SE, Brookes-Howell L, Dark P, Euden J, Hamilton R, Hellyer TP, Henley J, Hopkins S, Howard P, Howdon D, Knox-Macaulay C, Llewelyn MJ, Maboshe W, McCullagh IJ, Ogden M, Parsons HK, Partridge DG, Powell N, Prestwich G, Shaw D, Shinkins B, Szakmany T, Thomas-Jones E, Todd S, West RM, Carrol ED, Pallmann P. Sandoe JAT, et al. Among authors: albur m. J Antimicrob Chemother. 2024 Nov 4;79(11):2792-2800. doi: 10.1093/jac/dkae246. J Antimicrob Chemother. 2024. PMID: 39248146 Free PMC article.
The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study.
Webb EJD, Howdon D, Bestwick R, King N, Sandoe JAT, Euden J, Grozeva D, West R, Howard P, Powell N, Albur M, Bond S, Brookes-Howell L, Dark P, Hellyer T, Llewelyn M, McCullagh IJ, Ogden M, Pallmann P, Parsons H, Partridge D, Shaw D, Szakmany T, Todd S, Thomas-Jones E, Carrol ED, Shinkins B; PEACH Study Group. Webb EJD, et al. Among authors: albur m. J Antimicrob Chemother. 2024 Aug 1;79(8):1831-1842. doi: 10.1093/jac/dkae167. J Antimicrob Chemother. 2024. PMID: 38842487 Free PMC article.
Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study).
Henley J, Brookes-Howell L, Euden J, Pallmann P, Llewelyn M, Howard P, Powell N, Dark P, Szakmany T, Hellyer TP, Albur M, Hamilton R, Prestwich G, Ogden M, Maboshe W, Sandoe J, Thomas-Jones E, Carrol E; PEACH study group (Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients); PEACH consortium (Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients). Henley J, et al. Among authors: albur m. BMJ Open. 2023 Dec 19;13(12):e077117. doi: 10.1136/bmjopen-2023-077117. BMJ Open. 2023. PMID: 38114276 Free PMC article.
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model.
Attwood M, Griffin P, Noel AR, Albur M, Macgowan AP. Attwood M, et al. Among authors: albur m. J Antimicrob Chemother. 2023 Sep 5;78(9):2254-2262. doi: 10.1093/jac/dkad230. J Antimicrob Chemother. 2023. PMID: 37527369
Chronic or recurrent Campylobacter enteritis in primary immunodeficiency: A UK national case-series and review of the literature.
Grammatikos A, Thomas M, Johnston S, Moghaddas F, Albur M, Yong P, Buckland M, Grigoriadou S, Whyte AF, Herwadkar A, Gompels M. Grammatikos A, et al. Among authors: albur m. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2948-2954.e4. doi: 10.1016/j.jaip.2023.05.046. Epub 2023 Jun 8. J Allergy Clin Immunol Pract. 2023. PMID: 37301434 Free article. Review. No abstract available.
Procalcitonin Evaluation of Antibiotic Use in COVID-19 Hospitalised Patients (PEACH): Protocol for a Retrospective Observational Study.
Euden J, Pallmann P, Grozeva D, Albur M, Bond SE, Brookes-Howell L, Dark P, Hellyer T, Hopkins S, Howard P, Llewelyn MJ, Maboshe W, McCullagh IJ, Ogden M, Parsons H, Partridge D, Powell N, Shaw D, Shinkins B, Szakmany T, Todd S, Thomas-Jones E, West RM, Carrol ED, Sandoe JAT; PEACH Study Group. Euden J, et al. Among authors: albur m. Methods Protoc. 2022 Nov 28;5(6):95. doi: 10.3390/mps5060095. Methods Protoc. 2022. PMID: 36548137 Free PMC article.
Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK).
Goldenberg SD, Dodgson AR, Barlow G, Parcell BJ, Jones L, Albur M, Wilson APR, Enoch DA, Marek A, Micallef C, Manissero D, Longshaw C, Lopes S, Gill K. Goldenberg SD, et al. Among authors: albur m. Adv Ther. 2022 Aug;39(8):3602-3615. doi: 10.1007/s12325-022-02177-3. Epub 2022 Jun 14. Adv Ther. 2022. PMID: 35701725 Free PMC article.
34 results